The opposite correlations of the pro-resolving LM RvE1 and CD86 expression of myeloid dendritic cells in the NEDA and non-responding EDA RR-MS subgroup further support the idea of pre-existing MS subgroups or phenotypes in which different pathways are involved in disease pathogenesis. The gene discussed is CD86; the disease is myeloid sarcoma.